H. Ireland

1.3k total citations
47 papers, 987 citations indexed

About

H. Ireland is a scholar working on Hematology, Pulmonary and Respiratory Medicine and Surgery. According to data from OpenAlex, H. Ireland has authored 47 papers receiving a total of 987 indexed citations (citations by other indexed papers that have themselves been cited), including 31 papers in Hematology, 11 papers in Pulmonary and Respiratory Medicine and 8 papers in Surgery. Recurrent topics in H. Ireland's work include Blood Coagulation and Thrombosis Mechanisms (27 papers), Blood properties and coagulation (10 papers) and Venous Thromboembolism Diagnosis and Management (8 papers). H. Ireland is often cited by papers focused on Blood Coagulation and Thrombosis Mechanisms (27 papers), Blood properties and coagulation (10 papers) and Venous Thromboembolism Diagnosis and Management (8 papers). H. Ireland collaborates with scholars based in United Kingdom, Italy and France. H. Ireland's co-authors include David A. Lane, Elizabeth Thompson, A. Flynn, R.J. Olds, M Boisclair, Hediye Erdjument‐Bromage, J. Randall Curtis, G Kunz, Martine Aiach and Swee Lay Thein and has published in prestigious journals such as The Lancet, Journal of Biological Chemistry and Journal of Clinical Investigation.

In The Last Decade

H. Ireland

47 papers receiving 944 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
H. Ireland United Kingdom 21 677 253 192 166 162 47 987
Dorothée Kling Switzerland 9 604 0.9× 239 0.9× 211 1.1× 135 0.8× 168 1.0× 12 1.1k
WF Novotny United States 8 1.1k 1.6× 198 0.8× 249 1.3× 364 2.2× 172 1.1× 8 1.3k
Silvia Navarro Spain 22 413 0.6× 216 0.9× 194 1.0× 100 0.6× 159 1.0× 47 931
S I Rapaport United States 12 1.2k 1.8× 231 0.9× 217 1.1× 411 2.5× 322 2.0× 16 1.6k
M Drillings United States 8 508 0.8× 82 0.3× 172 0.9× 179 1.1× 190 1.2× 8 864
JP Miletich United States 13 1.4k 2.1× 237 0.9× 307 1.6× 458 2.8× 237 1.5× 15 1.7k
Hideo Kagawa Japan 16 570 0.8× 99 0.4× 187 1.0× 61 0.4× 149 0.9× 43 1.1k
Malcolm Cronlund United States 7 343 0.5× 146 0.6× 65 0.3× 102 0.6× 139 0.9× 9 641
Carla Boschetti Italy 18 340 0.5× 89 0.4× 209 1.1× 106 0.6× 276 1.7× 48 1.1k
Nina Lasky United States 10 662 1.0× 94 0.4× 108 0.6× 274 1.7× 92 0.6× 13 812

Countries citing papers authored by H. Ireland

Since Specialization
Citations

This map shows the geographic impact of H. Ireland's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by H. Ireland with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites H. Ireland more than expected).

Fields of papers citing papers by H. Ireland

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by H. Ireland. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by H. Ireland. The network helps show where H. Ireland may publish in the future.

Co-authorship network of co-authors of H. Ireland

This figure shows the co-authorship network connecting the top 25 collaborators of H. Ireland. A scholar is included among the top collaborators of H. Ireland based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with H. Ireland. H. Ireland is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Lytras, Spyros, Arthur Wickenhagen, Elena Sugrue, et al.. (2023). Resurrection of 2′-5′-oligoadenylate synthetase 1 (OAS1) from the ancestor of modern horseshoe bats blocks SARS-CoV-2 replication. PLoS Biology. 21(11). e3002398–e3002398. 2 indexed citations
2.
3.
Ireland, H., et al.. (1996). Directed Search For Thrombomodulin Gene Mutations. Pathophysiology of Haemostasis and Thrombosis. 26(Suppl. 4). 227–232. 6 indexed citations
4.
Simmonds, Rachel E., H. Ireland, G Kunz, et al.. (1996). Identification of 19 protein S gene mutations in patients with phenotypic protein S deficiency and thrombosis. Blood Coagulation & Fibrinolysis. 7(3). 373–373. 1 indexed citations
5.
Lane, David A., H. Ireland, J. Randall Curtis, et al.. (1992). Dermatan sulphate in haemodialysis. The Lancet. 339(8789). 334–335. 19 indexed citations
6.
Lane, David A., R.J. Olds, J. Conard, et al.. (1992). Pleiotropic effects of antithrombin strand 1C substitution mutations.. Journal of Clinical Investigation. 90(6). 2422–2433. 75 indexed citations
7.
Olds, R.J., David A. Lane, H. Ireland, et al.. (1991). Novel point mutations leading to type 1 antithrombin deficiency and thrombosis. British Journal of Haematology. 78(3). 408–413. 15 indexed citations
8.
Ireland, H., David A. Lane, Elizabeth Thompson, et al.. (1991). Antithrombin Glasgow II: alanine 382 to threonine mutation in the serpin P12 position, resulting in a substrate reaction with thrombin. British Journal of Haematology. 79(1). 70–74. 28 indexed citations
9.
Boisclair, M, David A. Lane, J Wilde, et al.. (1990). A comparative evaluation of assays for markers of activated coagulation and/or fibrinolysis: thrombin–antithrombin complex, D‐dimer and fibrinogen/fibrin fragment E antigen. British Journal of Haematology. 74(4). 471–479. 53 indexed citations
10.
11.
Ireland, H., et al.. (1989). Heparin as an anticoagulant during extracorporeal circulation. UCL Discovery (University College London). 8 indexed citations
12.
Gordge, M.P., et al.. (1989). Plasma D Dimer: A Useful Marker of Fibrin Breakdown in Renal Failure. Thrombosis and Haemostasis. 61(3). 522–525. 43 indexed citations
13.
Lane, David A., et al.. (1989). Heparin and Low Molecular Weight Heparin(oid)s as Anticoagulants in Hemodialysis for Chronic Renal Failure. Annals of the New York Academy of Sciences. 556(1). 456–458. 2 indexed citations
14.
Lane, David A., et al.. (1988). Relationship between ex vivo anti-proteinase (factor Xa and thrombin) assays and in vivo anticoagulant effect of very low molecular weight heparin, CY222. British Journal of Haematology. 70(3). 335–340. 13 indexed citations
15.
Lane, David A., et al.. (1988). Equivalent effective doses of heparin and low molecular weight heparin(oid)s in haemodialysis for chronic renal failure.. PubMed. 543. 101–4. 1 indexed citations
16.
Lane, David A., G.D.O. Lowe, A. Flynn, et al.. (1987). Antithrombin III Glasgow: a variant with increased heparin affinity and reduced ability to inactivate thrombin, associated with familial thrombosis. British Journal of Haematology. 66(4). 523–527. 25 indexed citations
17.
Hughes, Robin D., David A. Lane, H. Ireland, et al.. (1985). Fibrinogen derivatives and platelet activation products in acute and chronic liver disease. Clinical Science. 68(6). 701–707. 15 indexed citations
18.
Lane, David A., et al.. (1984). The significance of fibrinogen derivatives in plasma in human renal failure. British Journal of Haematology. 56(2). 251–260. 27 indexed citations
19.
Lane, David A., et al.. (1983). Activation of coagulation and fibrinolytic systems following stroke. British Journal of Haematology. 53(4). 655–658. 42 indexed citations
20.
Stoward, Peter J., et al.. (1981). Quantitative histochemical investigations of semipermeable membrane techniques for the assay of acid phosphatase in skeletal muscle. Histochemistry and Cell Biology. 71(4). 585–598. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Dorothée Kling Breakdown of academic impact, for papers by WF Novotny Breakdown of academic impact, for papers by Silvia Navarro Breakdown of academic impact, for papers by S I Rapaport Breakdown of academic impact, for papers by M Drillings Breakdown of academic impact, for papers by JP Miletich Breakdown of academic impact, for papers by Hideo Kagawa Breakdown of academic impact, for papers by Malcolm Cronlund Breakdown of academic impact, for papers by Carla Boschetti Breakdown of academic impact, for papers by Nina Lasky
Rankless by CCL
2026